• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道细菌、噬菌体和益生菌:三方共生关系以平息 SARS-CoV-2 风暴。

Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm.

机构信息

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Institute of Virology, Helmholtz Center Munich and Technical University of Munich, 85764, Neuherberg, Germany.

出版信息

Microb Pathog. 2022 Sep;170:105704. doi: 10.1016/j.micpath.2022.105704. Epub 2022 Aug 7.

DOI:10.1016/j.micpath.2022.105704
PMID:35948266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357283/
Abstract

Patients with SARS-CoV-2 infection, exhibit various clinical manifestations and severity including respiratory and enteric involvements. One of the main reasons for death among covid-19 patients is excessive immune responses directed toward cytokine storm with a low chance of recovery. Since the balanced gut microbiota could prepare health benefits by protecting against pathogens and regulating immune homeostasis, dysbiosis or disruption of gut microbiota could promote severe complications including autoimmune disorders; we surveyed the association between the imbalanced gut bacteria and the development of cytokine storm among COVID-19 patients, also the impact of probiotics and bacteriophages on the gut bacteria community to alleviate cytokine storm in COVID-19 patients. In present review, we will scrutinize the mechanism of immunological signaling pathways which may trigger a cytokine storm in SARS-CoV2 infections. Moreover, we are explaining in detail the possible immunological signaling pathway-directing by the gut bacterial community. Consequently, the specific manipulation of gut bacteria by using probiotics and bacteriophages for alleviation of the cytokine storm will be investigated. The tripartite mutualistic cooperation of gut bacteria, probiotics, and phages as a candidate prophylactic or therapeutic approach in SARS-CoV-2 cytokine storm episodes will be discussed at last.

摘要

感染 SARS-CoV-2 的患者表现出各种临床表现和严重程度,包括呼吸道和肠道受累。导致新冠病毒患者死亡的主要原因之一是针对细胞因子风暴的过度免疫反应,其恢复的可能性很低。由于平衡的肠道微生物群可以通过预防病原体和调节免疫稳态来提供健康益处,因此肠道微生物群的失调或破坏可能会导致严重的并发症,包括自身免疫性疾病;我们调查了 COVID-19 患者中肠道细菌失衡与细胞因子风暴发展之间的关系,以及益生菌和噬菌体对肠道细菌群落的影响,以减轻 COVID-19 患者的细胞因子风暴。在本次综述中,我们将仔细研究可能引发 SARS-CoV2 感染中细胞因子风暴的免疫信号通路的机制。此外,我们还详细解释了肠道细菌群落可能指导的免疫信号通路。因此,将通过使用益生菌和噬菌体来专门调节肠道细菌以减轻细胞因子风暴。最后,将讨论肠道细菌、益生菌和噬菌体的三方互利合作作为 SARS-CoV-2 细胞因子风暴发作的候选预防或治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/d42ed7abdaf2/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/b6243523ee42/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/39214e5488ae/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/b02b2104052f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/d42ed7abdaf2/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/b6243523ee42/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/39214e5488ae/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/b02b2104052f/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1852/9357283/d42ed7abdaf2/gr4_lrg.jpg

相似文献

1
Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm.肠道细菌、噬菌体和益生菌:三方共生关系以平息 SARS-CoV-2 风暴。
Microb Pathog. 2022 Sep;170:105704. doi: 10.1016/j.micpath.2022.105704. Epub 2022 Aug 7.
2
Probiotics and Coronavirus disease 2019: think about the link.益生菌与 2019 年冠状病毒病:关注二者的关联。
Br J Nutr. 2021 Nov 28;126(10):1564-1570. doi: 10.1017/S000711452000361X. Epub 2020 Sep 14.
3
COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.COVID-19 影响肠道菌群失调、急性后期后遗症、免疫调节和治疗方案。
Front Cell Infect Microbiol. 2024 May 28;14:1384939. doi: 10.3389/fcimb.2024.1384939. eCollection 2024.
4
Effect of probiotics as an immune modulator for the management of COVID-19.益生菌作为免疫调节剂在 COVID-19 管理中的作用。
Arch Microbiol. 2023 Apr 9;205(5):182. doi: 10.1007/s00203-023-03504-0.
5
Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.细胞因子风暴、中枢神经系统受累和 COVID-19 病毒感染的三角关系:sFasL 和神经纤毛蛋白-1 的作用。
Rev Neurosci. 2021 Jul 6;33(2):147-160. doi: 10.1515/revneuro-2021-0047. Print 2022 Feb 23.
6
Roles of the gut microbiota in severe SARS-CoV-2 infection.肠道微生物群在严重 SARS-CoV-2 感染中的作用。
Cytokine Growth Factor Rev. 2022 Feb;63:98-107. doi: 10.1016/j.cytogfr.2022.01.007. Epub 2022 Jan 31.
7
Cross-talk between immune system and microbiota in COVID-19.新型冠状病毒病中免疫系统与微生物组的串扰。
Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1281-1294. doi: 10.1080/17474124.2021.1991311. Epub 2021 Nov 2.
8
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.肠道微生物群与 COVID-19 进展的关系:对免疫发病机制和治疗的新认识。
Front Immunol. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336. eCollection 2023.
9
Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19.肠道微生物群可能成为 COVID-19 的潜在治疗途径。
Curr Pharm Biotechnol. 2022;23(15):1837-1850. doi: 10.2174/1389201023666220404183859.
10
SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的神经表现与细胞因子风暴交织在一起,这对治疗策略具有启示意义。
Curr Med Chem. 2022;29(12):2051-2074. doi: 10.2174/0929867328666210506161543.

引用本文的文献

1
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies.新型冠状病毒(SARS-CoV-2)的突变动态:对未来新冠疫苗策略的影响
Heliyon. 2024 Apr 25;10(9):e30208. doi: 10.1016/j.heliyon.2024.e30208. eCollection 2024 May 15.
2
Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis.布鲁氏菌 abortus 抗原 omp25 疫苗:基于乳球菌 lactis 的开发和靶向。
Vet Med Sci. 2023 Jul;9(4):1908-1922. doi: 10.1002/vms3.1173. Epub 2023 Jun 5.
3
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health.

本文引用的文献

1
The potential application of probiotics for the prevention and treatment of COVID-19.益生菌在预防和治疗新型冠状病毒肺炎中的潜在应用。
Egypt J Med Hum Genet. 2022;23(1):36. doi: 10.1186/s43042-022-00252-6. Epub 2022 Mar 25.
2
Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2.临床与实验噬菌体研究:针对 SARS-CoV-2 的可能应对方法的建议。
Microb Pathog. 2022 Mar;164:105442. doi: 10.1016/j.micpath.2022.105442. Epub 2022 Feb 10.
3
Regulatory T cells in COVID-19.
益生菌对免疫细胞的作用机制及其对人类健康的有益影响。
Cells. 2023 Jan 2;12(1):184. doi: 10.3390/cells12010184.
新冠病毒肺炎中的调节性T细胞
Aging Dis. 2021 Oct 1;12(7):1545-1553. doi: 10.14336/AD.2021.0709. eCollection 2021 Oct.
4
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism.SARS-CoV-2 感染通过增强 B 细胞代谢下调 B 细胞中 CD19 的表达从而导致恢复期患者免疫功能缺陷。
Signal Transduct Target Ther. 2021 Sep 22;6(1):345. doi: 10.1038/s41392-021-00749-3.
5
Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.肠道微生物群失调是导致老年、糖尿病和高血压患者新冠病毒疾病预后不良的关键因素。
Front Med (Lausanne). 2021 Aug 11;8:644751. doi: 10.3389/fmed.2021.644751. eCollection 2021.
6
Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy.噬菌体与动物和人体组织的相互作用——噬菌体治疗视角下的安全性问题。
Int J Mol Sci. 2021 Aug 19;22(16):8937. doi: 10.3390/ijms22168937.
7
Activation or exhaustion of CD8 T cells in patients with COVID-19.COVID-19 患者 CD8 T 细胞的激活或耗竭。
Cell Mol Immunol. 2021 Oct;18(10):2325-2333. doi: 10.1038/s41423-021-00750-4. Epub 2021 Aug 19.
8
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
9
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.树突状细胞缺陷在感染 SARS-CoV-2 七个月后仍然存在。
Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21.
10
Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein.肠道益生菌鼠李糖乳杆菌减轻 SARS-CoV-2 膜糖蛋白诱导的 PDE4B 介导热休克蛋白 6 诱导的白细胞介素-6。
J Nutr Biochem. 2021 Dec;98:108821. doi: 10.1016/j.jnutbio.2021.108821. Epub 2021 Jul 14.